Newswise — (New York – April 30, 2015) – With more than 50 presentations, New York Eye and Ear Infirmary of Mount Sinai and Mount Sinai Health System faculty are leading scientific contributors at the upcoming annual meeting of the Association of Research and Vision in Ophthalmology (ARVO), to be held May 3 – 7, 2015 in Denver, CO. ARVO is the world’s largest and most respected eye and vision research organizations. Each spring, the annual meeting draws approximately 10,000 scientists and physicians who present their latest research results to peers.

Presentations from Mount Sinai researchers at the Icahn School of Medicine include new revelations into how macular degeneration impacts patients with AIDS, the increasing resistance of ocular pathogens to conventional antibiotic treatments, the ability to track diabetes progression through the eyes, identification of novel biomarkers for primary open angle glaucoma, and the risk of corneal abrasions during lengthy surgical procedures. Key abstract presentations from the Mount Sinai Health System include:

Sunday, May 3: Embargoed: 8:30 amAntibiotic Resistance Among Ocular Pathogens – Results from the ARMOR Surveillance Study 2013-Present- Penny Asbell, MD, Professor of Ophthalmology and Director of the Cornea Service and Refractive Surgery Center, The Mount Sinai Hospital

Monday, May 4:Embargoed: 8:30 amPrevalence of Intermediate-Stage Age-Related Macular Degeneration in Patients with the Acquired Immunodeficiency Syndrome-Douglas Jabs, MD, Professor of Ophthalmology and Medicine and Chairman Emeritus of the Department of Ophthalmology, Icahn School of Medicine at Mount Sinai

Embargoed: 4:25 pmChanges Over Time in Retinal Vessels in Patients with Early Diabetes-Richard Rosen, MD, Professor of Ophthalmology, Vice Chair and Director of Ophthalmology Research, New York Eye and Ear Infirmary of Mount Sinai

Tuesday, May 5: Embargoed: 8:30 amCorneal Abrasion Following Anesthesia for Non-Ocular Surgical Procedures: A Case-Control Study- Priti Batta, MD, Assistant Professor of Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai - Ronald C. Gentile, MD, Professor of Ophthalmology and Director of the Ocular Trauma Service, New York Eye and Ear Infirmary of Mount Sinai

Embargoed: 3:45 pmDeveloping Micro-RNAs as Biomarkers for Primary Open Angle Glaucoma-Robert Ritch, MD, Shelley and Steven Einhorn Distinguished Chair, and Surgeon Director and Chief, Glaucoma Services, New York Eye and Ear Infirmary of Mount Sinai

For the full list of Mount Sinai ARVO 2015 presentations, please visit the NYEE website at –

About the Mount Sinai Health SystemThe Mount Sinai Health System is an integrated health system committed to providing distinguished care, conducting transformative research, and advancing biomedical education. Structured around seven member hospital campuses and a single medical school, the Health System has an extensive ambulatory network and a range of inpatient and outpatient services—from community‐based facilities to tertiary and quaternary care.

The System includes approximately 6,600 primary and specialty care physicians, 12‐minority‐owned free‐standing ambulatory surgery centers, over 45 ambulatory practices throughout the five boroughs of New York City, Westchester, and Long Island, as well as 31 affiliated community health centers. Physicians are affiliated with the Icahn School of Medicine at Mount Sinai, which is ranked among the top 20 medical schools both in National Institutes of Health funding and by U.S. News & World Report.For more information, visit, or find Mount Sinai onFacebook, Twitter and YouTube.